Editorial: The Risky Business of Fungal Infections in Patients with Cirrhosis.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 29610500.
- Also identified by DOI 10.1038/ajg.2018.20.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hospitalized patients with cirrhosis have a high rate of mortality. In the report by Bajaj et al., the negative impact of fungal infections (FI) on outcomes in a large US cohort of hospitalized cirrhotics is highlighted. Risk factors for FI are identified. Increasing awareness of FI along with the application of new diagnostic tools in species identification will provide the opportunity to improve patient outcomes.
Medical subject headings
- Liver Cirrhosis
- Mycoses